Ventas Cambio Fecha
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Amgen USD 10.4B 300M 2026-09
Arca Biopharma 0 0 2025-03
Bayer EUR 10.05B 820M 2026-09
Biogen USD 2.8B 60M 2026-09
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cytokinetics USD 47.6M 19M 2026-09
Eisai JPY 235.63B 1.3B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Exelixis USD 658.69M 30M 2026-09
Geron USD 60.19M 2.71M 2026-09
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
Merck USD 18.1B 1.5B 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09